Tenet Healthcare (NYSE:THC) Director Tammy Romo Sells 645 Shares

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 645 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $205.20, for a total transaction of $132,354.00. Following the transaction, the director owned 34,866 shares in the company, valued at $7,154,503.20. This represents a 1.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Tammy Romo also recently made the following trade(s):

• On Tuesday, November 4th, Tammy Romo sold 11,756 shares of Tenet Healthcare stock. The shares were sold at an average price of $204.07, for a total value of $2,399,046.92.
• On Monday, November 3rd, Tammy Romo sold 15,099 shares of Tenet Healthcare stock. The stock was sold at an average price of $200.81, for a total value of $3,032,030.19.

Tenet Healthcare Trading Up 0.4%

Shares of THC stock opened at $204.99 on Friday. The stock has a 50-day simple moving average of $198.15 and a 200 day simple moving average of $175.72. The stock has a market capitalization of $18.02 billion, a P/E ratio of 14.05, a P/E/G ratio of 0.89 and a beta of 1.53. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $217.43. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.27.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. Tenet Healthcare’s revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the stock. SVB Wealth LLC bought a new position in Tenet Healthcare in the 1st quarter worth $30,000. N.E.W. Advisory Services LLC bought a new position in shares of Tenet Healthcare in the first quarter worth about $31,000. Brooklyn Investment Group lifted its position in shares of Tenet Healthcare by 908.7% during the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock worth $31,000 after purchasing an additional 209 shares during the last quarter. William B. Walkup & Associates Inc. bought a new stake in Tenet Healthcare during the 3rd quarter valued at approximately $32,000. Finally, Chung Wu Investment Group LLC bought a new position in Tenet Healthcare in the 2nd quarter worth approximately $35,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

THC has been the topic of several research reports. Raymond James Financial set a $245.00 price target on Tenet Healthcare in a report on Wednesday, October 29th. KeyCorp boosted their target price on Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Wolfe Research cut Tenet Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. UBS Group upped their price objective on shares of Tenet Healthcare from $238.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, Truist Financial restated a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $226.25.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.